Jamey Millar joins Novo Nordisk as executive vice president, US Operations

Novo Nordisk named Jamey Millar executive vice president of US Operations, effective February 2026. The US business is where pricing pressure and competition are most intense, so the appointment matters for volume and price trends. Traders will watch whether the new US leadership changes the pace of price cuts or the push into cash-pay channels.

• Role: executive vice president, US Operations
• Effective: February 2026
• Leads the US business, the main arena for price pressure and competition